Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Operating Expenses | 22,814 | 16,443 | 4,718 | 0 |
| Operating Income | -22,814 | -16,443 | -4,718 | N/A |
| Interest Expense | 4,580 | 2,719 | 157 | 0 |
| Other Income | -27,244 | -5,315 | -371 | 0 |
| Pre-tax Income | -54,638 | -24,477 | -5,246 | 0 |
| Income Tax | 26 | -22 | -20 | N/A |
| Net Income Continuous | -54,664 | -24,455 | -5,226 | N/A |
| Net Income | $-54,664 | $-24,455 | $-5,226 | $N/A |
| EPS Basic Total Ops | -118.72 | -164.32 | -35.20 | N/A |
| EPS Basic Continuous Ops | -118.69 | -164.33 | -35.12 | N/A |
| EPS Diluted Total Ops | -118.72 | -164.32 | -35.20 | N/A |
| EPS Diluted Continuous Ops | -118.69 | -164.33 | -35.12 | N/A |
| EBITDA(a) | $-20,821 | $-15,254 | $-3,090 | $N/A |